Gavin Corcoran - 31 Mar 2025 Form 3 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Role
Director
Signature
/s/ Christopher Hayes, Attormey-in-Fact
Issuer symbol
VRCA
Transactions as of
31 Mar 2025
Net transactions value
$0
Form type
3
Filing time
02 Apr 2025, 16:31:50 UTC
Next filing
09 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VRCA Common Stock 20 31 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.